Tag Archives: AKBA

Top 10 Medical Stocks To Buy For 2019

It turns out that most Americans know very little about the state of their own medical benefits, particularly when it comes to out-of-pocket healthcare costs.

A survey released by Sun Life yesterday revealed that a whopping 54% of working Americans don’t know what the out-of-pocket maximum is for their own healthcare plans.

This statistic truly highlights the financial risk associated with individuals trying to save for retirement and successfully grow their wealth: that such planning cannot accurately be achieved without knowing first what kind of financial effect a major medical event could one day have on them.

Don’t Miss:Eight Times the Government Was Warned About Obamacare Fraud – and Did Nothing

To make matters worse, a particular niche of those surveyed revealed themselves to be arguably in an even tougher financial spot…

Top 10 Medical Stocks To Buy For 2019: Intercept Pharmaceuticals, Inc.(ICPT)

Advisors’ Opinion:

  • [By Sean Williams, Chuck Saletta, and Brian Feroldi]

    With this in mind, we picked the brains of three Motley Fool investors to gauge what biotech stock they believe investors should consider buying right now. Topping the list were mid-caps Intercept Pharmaceuticals (NASDAQ:ICPT) and Xencor (NASDAQ:XNCR), as well as biotech blue-chip Celgene (NASDAQ:CELG).

  • [By Max Byerly]

    News headlines about Intercept Pharmaceuticals (NASDAQ:ICPT) have trended somewhat positive recently, Accern Sentiment Analysis reports. The research group scores the sentiment of press coverage by monitoring more than 20 million blog and news sources. Accern ranks coverage of companies on a scale of -1 to 1, with scores closest to one being the most favorable. Intercept Pharmaceuticals earned a news impact score of 0.12 on Accern’s scale. Accern also gave news articles about the biopharmaceutical company an impact score of 46.6381898611919 out of 100, meaning that recent press coverage is somewhat unlikely to have an impact on the stock’s share price in the near future.

  • [By Stephan Byrd]

    Get a free copy of the Zacks research report on Intercept Pharmaceuticals (ICPT)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Ethan Ryder]

    US Bancorp DE grew its stake in Intercept Pharmaceuticals (NASDAQ:ICPT) by 821.6% during the 1st quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor owned 1,751 shares of the biopharmaceutical company’s stock after purchasing an additional 1,561 shares during the period. US Bancorp DE’s holdings in Intercept Pharmaceuticals were worth $108,000 at the end of the most recent quarter.

  • [By Sean Williams]

    As you can see, there’s a lot of excitement in the NASH space at the moment, and plenty of big drug stocks are itching to add a promising NASH drug to their product pipelines. But one name that continues to be left out in the cold is Intercept Pharmaceuticals (NASDAQ:ICPT).

  • [By George Budwell]

    If that line holds true, this emerging space should be able to support multiple new drugs, meaning that the current leaders in the field –Intercept Pharmceuticals (NASDAQ:ICPT) and Genfit — probably won’t be able to monopolize the market before other competitors like Viking get their drugs past the FDA. In fact, this market is so large it could feasibly support several blockbuster level products.

Top 10 Medical Stocks To Buy For 2019: Clearside BioMedical, Inc. (CLSD)

Advisors’ Opinion:

  • [By Ethan Ryder]

    Here are some of the news articles that may have effected Accern Sentiment Analysis’s analysis:

    Get Catabasis Pharmaceuticals alerts:

    Analysts Offer Insights on Healthcare Companies: Clearside Biomedical (NASDAQ: CLSD) and Bluebird Bio (NASDAQ … (analystratings.com) Catabasis launches public equity offering (seekingalpha.com) Friedreich Ataxia Market Pipeline Therapeutics 2018 Top Key Players, Drug Profile and Product Description (thecleantechnology.com) Cellectis SA Receives a Buy from Oppenheimer (analystratings.com) Global Type I Hyperlipoproteinemia Drug Market 2018- Catabasis Pharmaceuticals, Inc., uniQure NV , Isis … (afinancialanalysis.com)

    Shares of Catabasis Pharmaceuticals traded down $0.28, reaching $1.06, on Monday, Marketbeat reports. The company’s stock had a trading volume of 2,344,684 shares, compared to its average volume of 645,019. The firm has a market cap of $38.91 million, a price-to-earnings ratio of -0.84 and a beta of 0.74. Catabasis Pharmaceuticals has a 52 week low of $1.00 and a 52 week high of $3.78.

  • [By Lisa Levin]

      

    Clearside Biomedical, Inc. (NASDAQ: CLSD) shares declined 32.19 percent to close at $9.86 on Thursday. Clearside Biomedical disclosed that its Phase 2 trial of CLS-TA met primary and secondary endpoints met in 6-month trial.
    scPharmaceuticals Inc. (NASDAQ: SCPH) shares dipped 30.1 percent to close at $9.94 on Thursday after the FDA identified deficiencies in the company’s New Drug Application for FUROSCIX. However, the FDA letter did not specify deficiencies identified and notification does not reflect final decision on information under review.
    Euroseas Ltd. (NASDAQ: ESEA) fell 24.08 percent to close at $1.86. Euroseas announced completion of the spin-off of its drybulk fleet into EuroDry Ltd.
    Golar LNG Limited (NASDAQ: GLNG) fell 25.09 percent to close at $25.98 following Q1 results.
    Oragenics, Inc. (NASDAQ: OGEN) shares dropped 25 percent to close at $1.50 on Thursday.
    Guess', Inc. (NYSE: GES) dropped 19.44 percent to close at $19.60 following Q1 results.
    Cantel Medical Corp. (NYSE: CMD) dropped 15.94 percent to close at $109.09 on Thursday following FQ3 results.
    Fusion Connect, Inc. (NASDAQ: FSNN) shares fell 15.55 percent to close at $3.91.
    Build-A-Bear Workshop, Inc. (NYSE: BBW) dropped 14.44 percent to close at $8.00 after reporting Q1 results.
    Dollar Tree, Inc. (NASDAQ: DLTR) shares declined 14.28 percent to close at $82.59 after the company reported weaker-than-expected earnings for its first quarter and lowered its FY2018 earnings guidance.
    Titan Machinery Inc. (NASDAQ: TITN) dropped 13.94 percent to close at $18.09 after reporting Q1 results.
    Co-Diagnostics, Inc. (NASDAQ: CODX) declined 13.17 percent to close at $2.90 after declining 5.65 percent on Wednesday.
    Concordia International Corp. (NASDAQ: CXRX) fell 12.89 percent to close at $0.2440 after the company announced that it would be delisted from the Nasdaq.
    Sears Holdings Corporation (NASDAQ: SHLD) slipped 12.46 percent

  • [By Keith Noonan]

    Clearside Biomedical, Inc. Stock (NASDAQ:CLSD)stock rose 66.1% in March, according to data provided byS&P Global Market Intelligence.

Top 10 Medical Stocks To Buy For 2019: Gorman-Rupp Company (GRC)

Advisors’ Opinion:

  • [By Logan Wallace]

    US Bancorp DE lessened its stake in shares of Gorman-Rupp (NYSE:GRC) by 3.6% during the 1st quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm owned 136,614 shares of the industrial products company’s stock after selling 5,085 shares during the period. US Bancorp DE’s holdings in Gorman-Rupp were worth $3,996,000 at the end of the most recent reporting period.

Top 10 Medical Stocks To Buy For 2019: Blackrock Health Sciences Trust(BME)

Advisors’ Opinion:

  • [By Stephan Byrd]

    Shares of B&M European Value Retail SA (LON:BME) have earned an average recommendation of “Buy” from the sixteen ratings firms that are covering the firm, MarketBeat Ratings reports. Five research analysts have rated the stock with a hold rating and eleven have issued a buy rating on the company. The average 12-month price target among brokers that have covered the stock in the last year is GBX 442.92 ($5.90).

  • [By Max Byerly]

    B&M European Value Retail (LON:BME) had its target price boosted by analysts at HSBC from GBX 470 ($6.26) to GBX 500 ($6.66) in a report released on Wednesday. The brokerage presently has a “buy” rating on the stock. HSBC’s price objective indicates a potential upside of 21.54% from the company’s current price.

Top 10 Medical Stocks To Buy For 2019: Liberty Property Trust(LPT)

Advisors’ Opinion:

  • [By Stephan Byrd]

    Get a free copy of the Zacks research report on Liberty Property Trust (LPT)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Max Byerly]

    Get a free copy of the Zacks research report on Liberty Property Trust (LPT)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Shane Hupp]

    DekaBank Deutsche Girozentrale lowered its position in shares of Liberty Property Trust (NYSE:LPT) by 11.7% during the first quarter, according to its most recent disclosure with the Securities & Exchange Commission. The firm owned 12,176 shares of the real estate investment trust’s stock after selling 1,608 shares during the period. DekaBank Deutsche Girozentrale’s holdings in Liberty Property Trust were worth $515,000 as of its most recent SEC filing.

Top 10 Medical Stocks To Buy For 2019: Eaton Vance New York Municipal Bond Fund(ENX)

Advisors’ Opinion:

  • [By Logan Wallace]

    Eaton Vance New York Municipal Bond Fund (NYSEAMERICAN:ENX) announced a monthly dividend on Thursday, July 5th, Wall Street Journal reports. Investors of record on Tuesday, July 24th will be paid a dividend of 0.0448 per share on Tuesday, July 31st. This represents a $0.54 dividend on an annualized basis and a dividend yield of 4.75%. The ex-dividend date of this dividend is Monday, July 23rd.

  • [By Logan Wallace]

    Eaton Vance New York Municipal Bond Fund (NYSEAMERICAN:ENX) announced a monthly dividend on Monday, June 4th, Wall Street Journal reports. Shareholders of record on Friday, June 22nd will be given a dividend of 0.0448 per share on Friday, June 29th. This represents a $0.54 annualized dividend and a yield of 4.77%. The ex-dividend date of this dividend is Thursday, June 21st.

  • [By Joseph Griffin]

    Euronext Amsterdam (EPA:ENX) has been assigned a €51.00 ($60.71) price target by investment analysts at UBS in a note issued to investors on Wednesday, www.boersen-zeitung.de reports. The firm presently has a “sell” rating on the stock. UBS’s target price would suggest a potential downside of 15.63% from the stock’s current price.

Top 10 Medical Stocks To Buy For 2019: Navios Maritime Partners LP(NMM)

Advisors’ Opinion:

  • [By Ethan Ryder]

    Get a free copy of the Zacks research report on Navios Maritime Partners (NMM)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

Top 10 Medical Stocks To Buy For 2019: PetSmart Inc(PETM)

Advisors’ Opinion:

  • [By Shane Hupp]

    An issue of PetSmart, Inc. (NASDAQ:PETM) debt rose 1% against its face value during trading on Monday. The high-yield debt issue has a 8.875% coupon and is set to mature on June 1, 2025. The debt is now trading at $67.50 and was trading at $66.25 last week. Price moves in a company’s debt in credit markets often anticipate parallel moves in its share price.

  • [By Joseph Griffin]

    An issue of PetSmart, Inc. (NASDAQ:PETM) bonds fell 1.6% as a percentage of their face value during trading on Wednesday. The high-yield debt issue has a 8.875% coupon and is set to mature on June 1, 2025. The debt is now trading at $49.19 and was trading at $55.47 one week ago. Price changes in a company’s bonds in credit markets often predict parallel changes in its stock price.

Top 10 Medical Stocks To Buy For 2019: Akebia Therapeutics, Inc.(AKBA)

Advisors’ Opinion:

  • [By WWW.GURUFOCUS.COM]

    For the details of Novo A’s stock buys and sells, go to www.gurufocus.com/StockBuy.php?GuruName=Novo+A

    These are the top 5 holdings of Novo AInogen Inc (INGN) – 3,549,320 shares, 59.83% of the total portfolio. Acceleron Pharma Inc (XLRN) – 1,553,937 shares, 9.34% of the total portfolio. Dermira Inc (DERM) – 1,984,364 shares, 7.81% of the total portfolio. Shares added by 3.27%Corvus Pharmaceuticals Inc (CRVS) – 3,244,046 shares, 4.76% of the total portfolio. Akebia Therapeutics Inc (AKBA) – 2,225,000 shares, 4

  • [By Stephan Byrd]

    PNC Financial Services Group Inc. grew its holdings in shares of Akebia Therapeutics Inc. (NASDAQ:AKBA) by 653,850.0% in the 1st quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 313,896 shares of the biopharmaceutical company’s stock after buying an additional 313,848 shares during the quarter. PNC Financial Services Group Inc. owned 0.55% of Akebia Therapeutics worth $2,991,000 at the end of the most recent quarter.

  • [By Brian Feroldi]

    In response to the companies signing a merger agreement, shares ofAkebia Therapeutics (NASDAQ:AKBA) and Keryx Biopharmaceuticals (NASDAQ:KERX)fell 18% and 12%, respectively, as of 10:47 a.m. EDT on Thursday.

Top 10 Medical Stocks To Buy For 2019: International Bancshares Corporation(IBOC)

Advisors’ Opinion:

  • [By Stephan Byrd]

    International Bancshares (NASDAQ: IBOC) and First Business Financial Services (NASDAQ:FBIZ) are both finance companies, but which is the better investment? We will contrast the two businesses based on the strength of their profitability, analyst recommendations, earnings, institutional ownership, dividends, valuation and risk.

  • [By Ethan Ryder]

    BidaskClub upgraded shares of International Bancshares (NASDAQ:IBOC) from a hold rating to a buy rating in a research note published on Saturday.

    International Bancshares opened at $43.65 on Friday, MarketBeat reports. International Bancshares has a 1 year low of $32.50 and a 1 year high of $43.75. The company has a quick ratio of 0.73, a current ratio of 0.73 and a debt-to-equity ratio of 0.54. The stock has a market capitalization of $2.83 billion, a price-to-earnings ratio of 15.97 and a beta of 1.46.

  • [By Joseph Griffin]

    Shares of International Bancshares Co. (NASDAQ:IBOC) hit a new 52-week high and low during trading on Tuesday . The stock traded as low as $44.40 and last traded at $44.25, with a volume of 11252 shares. The stock had previously closed at $43.90.

Top 10 Clean Energy Stocks To Watch For 2019

Uranium has been back in the news lately, not only due to its relationship with geopolitical maneuvering concerning nuclear weapons, but also as a necessary commodity in the global quest for clean, renewable energy.

The United States is the world’s largest producer of nuclear power, accounting for more than 30% of worldwide nuclear generation of electricity. While there has been little growth in new reactors being built in the last quarter century, the increasing demand for clean energy worldwide is sparking a demand for uranium to be enriched as nuclear fuel. Companies that mine and produce uranium, like Azincourt Uranium, Inc. (OTC: AZURF), are seeing the commodity investment market take a renewed interest in them, with uranium spot prices trending upward in the first quarter of 2017.

Top 10 Clean Energy Stocks To Watch For 2019: Vanguard Mega Cap Growth ETF (MGK)

Advisors’ Opinion:

  • [By Ethan Ryder]

    Fernwood Investment Management LLC lessened its stake in VANGUARD MEGA CAP 300 GROWTH ETF (BMV:MGK) by 9.1% in the 1st quarter, according to the company in its most recent Form 13F filing with the SEC. The firm owned 17,022 shares of the company’s stock after selling 1,698 shares during the period. VANGUARD MEGA CAP 300 GROWTH ETF comprises 1.1% of Fernwood Investment Management LLC’s portfolio, making the stock its 26th biggest holding. Fernwood Investment Management LLC owned approximately 0.06% of VANGUARD MEGA CAP 300 GROWTH ETF worth $1,911,000 as of its most recent filing with the SEC.

Top 10 Clean Energy Stocks To Watch For 2019: Marvell Technology Group Ltd.(MRVL)

Advisors’ Opinion:

  • [By Harsh Chauhan]

    Chipmakers Micron Technology (NASDAQ:MU) and Marvell Technology Group (NASDAQ:MRVL) have been riding high on growing memory demand. Both companies have outpaced the NASDAQ-100 Technology Sector index quite comfortably over the past year as the increase in demand for DRAM (dynamic random access memory), flash memory, and hard-disk drives (HDD) has rubbed off positively on their businesses.

  • [By Joseph Griffin]

    ETRADE Capital Management LLC raised its position in Marvell Technology Group (NASDAQ:MRVL) by 51.5% in the 1st quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 59,214 shares of the semiconductor company’s stock after purchasing an additional 20,122 shares during the period. ETRADE Capital Management LLC’s holdings in Marvell Technology Group were worth $1,243,000 at the end of the most recent reporting period.

  • [By Chris Lange]

    When Marvell Technology Group Ltd. (NASDAQ: MRVL) released its fiscal first-quarter financial results late on Thursday, the company said that it had $0.32 in earnings per share (EPS) and $604.6 million in revenue. Consensus estimates had called for $0.31 in EPS on revenue of $602.01 million. In the same period of last year, Marvell said it had EPS of $0.24 and $579.18 million in revenue.

Top 10 Clean Energy Stocks To Watch For 2019: GRAVITY Co. Ltd.(GRVY)

Advisors’ Opinion:

  • [By Max Byerly]

    ILLEGAL ACTIVITY WARNING: “Gravity (GRVY) Receives Coverage Optimism Score of 0.17” was first published by Ticker Report and is the sole property of of Ticker Report. If you are viewing this story on another publication, it was copied illegally and reposted in violation of U.S. & international trademark and copyright laws. The legal version of this story can be viewed at www.tickerreport.com/banking-finance/3382037/gravity-grvy-receives-coverage-optimism-score-of-0-17.html.

  • [By Joseph Griffin]

    BidaskClub upgraded shares of Gravity (NASDAQ:GRVY) from a strong sell rating to a sell rating in a research note issued to investors on Tuesday morning.

  • [By Cooper Creagan]

    For example, if you had taken five minutes to set up a Night Trade on Gravity Co. (Nasdaq: GRVY) in October, you could’ve tripled your money, and then some.

Top 10 Clean Energy Stocks To Watch For 2019: Anadarko Petroleum Corporation(APC)

Advisors’ Opinion:

  • [By Lee Jackson]

    This top company is still down a stunning 30% from highs printed in 2014, the last time oil traded at $70. Anadarko Petroleum Corp. (NYSE: APC) operates through three segments. The Oil and Gas Exploration and Production segment explores for and produces natural gas, oil, condensate, and natural gas liquids (NGLs). The other segments areMidstream and Marketing.

  • [By Shane Hupp]

    AlpaCoin (CURRENCY:APC) traded flat against the U.S. dollar during the 1-day period ending at 20:00 PM E.T. on May 30th. AlpaCoin has a total market cap of $0.00 and $0.00 worth of AlpaCoin was traded on exchanges in the last day. During the last seven days, AlpaCoin has traded down 74.2% against the U.S. dollar. One AlpaCoin coin can now be purchased for about $0.0003 or 0.00000004 BTC on cryptocurrency exchanges.

  • [By Matthew DiLallo]

    Western Gas Partners, like Shell Midstream, is also an MLP with an oil-producing parent, in this caseAnadarko Petroleum (NYSE:APC). That relationship has enabled Western Gas Partners to steadily grow cash flow and its distribution, initially via dropdown acquisitions and more recently from organic expansion projects. Those dual fuels enabled the MLP to increase its payout for 36 consecutive quarters.

  • [By ]

    Cramer and the AAP team have been looking for a new name to play in light of higher energy prices. Their choice? Andadarko Petroleum (APC) . Find out what they’re telling their investment club members and get in on the conversation with a free trial subscription to Action Alerts PLUS.

  • [By Matthew DiLallo]

    Last fall, ConocoPhillips (NYSE:COP) outlined its three-year operating plan, anticipating that it could increase production at a 5% compound annual growth rate assuming oil averaged $50 a barrel. While the return to a growth trajectory was nice to see, its forecast paled in comparison to rivals like EOG Resources (NYSE:EOG) and Anadarko Petroleum (NYSE:APC), which both project double-digit oil production growth rates over the next few years.

Top 10 Clean Energy Stocks To Watch For 2019: Universal Health Services, Inc.(UHS)

Advisors’ Opinion:

  • [By Max Byerly]

    Parametrica Management Ltd acquired a new stake in Universal Health Services (NYSE:UHS) during the 1st quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor acquired 1,694 shares of the health services provider’s stock, valued at approximately $201,000.

  • [By Logan Wallace]

    TheStreet cut shares of Universal Health Services, Inc. Class B (NYSE:UHS) from a b rating to a c+ rating in a research note published on Friday morning.

  • [By Reuben Gregg Brewer]

    An aging baby boomer population is set to boost results at HCP, Inc. (NYSE:HCP) andUniversal Health Services, Inc. (NYSE:UHS) for years to come. But is it better to own physical assets, like real estate investment trust HCP, or run them, like health facility operator Universal? In the end, these two companies are very similar but also differ in many ways. Here’s what you need to know to pick the one that’s right for you.

  • [By Shane Hupp]

    Nomura Asset Management Co. Ltd. boosted its stake in shares of Universal Health Services, Inc. Class B (NYSE:UHS) by 130.4% in the first quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 53,657 shares of the health services provider’s stock after buying an additional 30,365 shares during the quarter. Nomura Asset Management Co. Ltd. owned approximately 0.06% of Universal Health Services, Inc. Class B worth $6,353,000 as of its most recent SEC filing.

  • [By Stephan Byrd]

    Quorum Health (NYSE: QHC) and Universal Health Services (NYSE:UHS) are both medical companies, but which is the superior stock? We will compare the two companies based on the strength of their analyst recommendations, valuation, dividends, institutional ownership, profitability, earnings and risk.

Top 10 Clean Energy Stocks To Watch For 2019: Red Lion Hotels Corporation(RLH)

Advisors’ Opinion:

  • [By Ethan Ryder]

    These are some of the media stories that may have impacted Accern Sentiment’s scoring:

    Get Red Lion Hotels alerts:

    Contrasting Hilton Worldwide (HLT) and Red Lion Hotels (RLH) (americanbankingnews.com) Red Lion Hotels Co. (RLH) Director Sells $838,969.60 in Stock (americanbankingnews.com) Insider Selling: Red Lion Hotels Co. (RLH) Director Sells 178,000 Shares of Stock (americanbankingnews.com) Red Lion Hotels Co. (RLH) Major Shareholder Sells $5,099,986.65 in Stock (americanbankingnews.com) RLH Corporation Promotes Paul Sacco to Executive Vice President, President of Global Development (finance.yahoo.com)

    Several equities analysts have recently weighed in on the company. ValuEngine upgraded Red Lion Hotels from a “buy” rating to a “strong-buy” rating in a research report on Thursday, June 7th. Zacks Investment Research upgraded Red Lion Hotels from a “sell” rating to a “hold” rating in a research report on Wednesday, May 30th.

  • [By Shane Hupp]

    Red Lion Hotels (NYSE: RLH) and Wynn Resorts (NASDAQ:WYNN) are both consumer discretionary companies, but which is the superior investment? We will compare the two companies based on the strength of their risk, institutional ownership, dividends, analyst recommendations, valuation, profitability and earnings.

Top 10 Clean Energy Stocks To Watch For 2019: Horizon Global Corporation(HZN)

Advisors’ Opinion:

  • [By Brian Feroldi]

    Horizon Global(NYSE:HZN)reported its first-quarter results on May 3. The provider ofbranded towing and trailering equipment had already warned investors that it was going through tough times but promised that it would take action to fix its problems.Let’s dig into the company’s results to see if those actions are starting to pay off.

  • [By Stephan Byrd]

    Horizon Global (NYSE:HZN) has earned an average rating of “Hold” from the ten research firms that are presently covering the stock, Marketbeat Ratings reports. Three equities research analysts have rated the stock with a sell rating, three have issued a hold rating and three have given a buy rating to the company. The average 1-year price target among brokerages that have issued ratings on the stock in the last year is $15.08.

  • [By Lisa Levin]

     

    Losers
    Heat Biologics, Inc. (NASDAQ: HTBX) shares tumbled 48.59 percent to close at $1.275 on Thursday after the company priced its $18,000,000 public offering.
    InVivo Therapeutics Holdings Corp. (NASDAQ: NVIV) fell 38.77 percent to close at $8.26 on Thursday.
    Check-Cap Ltd. (NASDAQ: CHEK) shares tumbled 27.43 percent to close at $8.81.
    Achaogen, Inc. (NASDAQ: AKAO) dropped 24.76 percent to close at $11.06 in reaction to a disappointing update from an FDA AdCom panel. The FDA panel voted favorably for the company's Plazcomicin for treatment of adults with complicated urinary tract infections, but also voted against the therapy to be used as a treatment for bloodstream infections.
    Anika Therapeutics, Inc. (NASDAQ: ANIK) shares declined 24.68 percent to close at $34.80 after the company posted downbeat quarterly results.
    LSC Communications, Inc. (NASDAQ: LKSD) shares fell 24.22 percent to close at $12.64 following wider-than-expected Q1 loss.
    Cardinal Health, Inc. (NYSE: CAH) fell 21.42 percent to close at $50.80 following downbeat quarterly profit.
    Horizon Global Corporation (NYSE: HZN) dropped 20.42 percent to close at $6.00 following downbeat quarterly earnings.
    Hornbeck Offshore Services, Inc. (NYSE: HOS) slipped 20.11 percent to close at $2.90 following wider-than-expected Q1 loss.
    Esperion Therapeutics, Inc. (NASDAQ: ESPR) fell 19.28 percent to close at $36.93. Esperion Therapeutics stock lost roughly a third of its value Wednesday after the company reported mixed Phase III results for its leading drug candidate, bempedoic acid. JP Morgan downgraded Esperion Therapeutics from Neutral to Underweight.
    Laredo Petroleum, Inc. (NYSE: LPI) declined 17.77 percent to close at $8.98 after the company reported weaker-than-expected Q1 earnings.
    The Habit Restaurants, Inc. (NASDAQ: HABT) dipped 16.1 percent to close at $8.60 after the company reported downbeat quarterly results.
    Arcadia Biosciences, Inc. (N

  • [By Stephan Byrd]

    Horizon Global (NYSE:HZN) had its price target upped by research analysts at Roth Capital from $6.50 to $7.50 in a research note issued to investors on Friday. The brokerage currently has a “neutral” rating on the stock. Roth Capital’s target price indicates a potential upside of 20.97% from the stock’s current price.

Top 10 Clean Energy Stocks To Watch For 2019: Nuveen Preferred Income Opportunites Fund(JPC)

Advisors’ Opinion:

  • [By Ethan Ryder]

    News headlines about Nuveen Preferred & Income Oprtnts Fnd (NYSE:JPC) have trended positive this week, according to Accern Sentiment. The research group rates the sentiment of press coverage by analyzing more than 20 million news and blog sources. Accern ranks coverage of public companies on a scale of negative one to positive one, with scores closest to one being the most favorable. Nuveen Preferred & Income Oprtnts Fnd earned a media sentiment score of 0.42 on Accern’s scale. Accern also gave news coverage about the financial services provider an impact score of 48.1302177844966 out of 100, meaning that recent press coverage is somewhat unlikely to have an effect on the stock’s share price in the next few days.

Top 10 Clean Energy Stocks To Watch For 2019: Akebia Therapeutics, Inc.(AKBA)

Advisors’ Opinion:

  • [By Brian Feroldi]

    In response to the companies signing a merger agreement, shares ofAkebia Therapeutics (NASDAQ:AKBA) and Keryx Biopharmaceuticals (NASDAQ:KERX)fell 18% and 12%, respectively, as of 10:47 a.m. EDT on Thursday.

  • [By Stephan Byrd]

    PNC Financial Services Group Inc. grew its holdings in shares of Akebia Therapeutics Inc. (NASDAQ:AKBA) by 653,850.0% in the 1st quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 313,896 shares of the biopharmaceutical company’s stock after buying an additional 313,848 shares during the quarter. PNC Financial Services Group Inc. owned 0.55% of Akebia Therapeutics worth $2,991,000 at the end of the most recent quarter.

  • [By WWW.GURUFOCUS.COM]

    For the details of Novo A’s stock buys and sells, go to www.gurufocus.com/StockBuy.php?GuruName=Novo+A

    These are the top 5 holdings of Novo AInogen Inc (INGN) – 3,549,320 shares, 59.83% of the total portfolio. Acceleron Pharma Inc (XLRN) – 1,553,937 shares, 9.34% of the total portfolio. Dermira Inc (DERM) – 1,984,364 shares, 7.81% of the total portfolio. Shares added by 3.27%Corvus Pharmaceuticals Inc (CRVS) – 3,244,046 shares, 4.76% of the total portfolio. Akebia Therapeutics Inc (AKBA) – 2,225,000 shares, 4

Top 10 Clean Energy Stocks To Watch For 2019: Golden Ocean Group Limited(GOGL)

Advisors’ Opinion:

  • [By Ethan Ryder]

    Jane Street Group LLC raised its holdings in shares of Golden Ocean Group Ltd (NASDAQ:GOGL) by 99.4% during the 1st quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The fund owned 224,567 shares of the shipping company’s stock after purchasing an additional 111,971 shares during the period. Jane Street Group LLC owned approximately 0.16% of Golden Ocean Group worth $1,785,000 at the end of the most recent quarter.

  • [By Lisa Levin] Gainers
    Sanmina Corp (NASDAQ: SANM) shares rose 15.2 percent to $31.90 in pre-market trading as the company reported stronger-than-expected earnings for its second quarter on Monday.
    Cadence Design Systems, Inc. (NASDAQ: CDNS) rose 12.4 percent to $41.30 in pre-market trading after the company posted upbeat Q1 results and issued a strong Q2 forecast.
    Aeglea BioTherapeutics, Inc. (NASDAQ: AGLE) rose 10.8 percent to $8.75 in pre-market trading.
    Mitel Networks Corporation (NASDAQ: MITL) rose 8.8 percent to $11.05 in pre-market trading after the company agreed to be acquired by affiliates of Searchlight Capital Partners for $2.0 billion.
    Galectin Therapeutics, Inc. (NASDAQ: GALT) rose 7.3 percent to $3.70 in pre-market trading.
    Riot Blockchain, Inc. (NASDAQ: RIOT) shares rose 6.9 percent to $7.00 in pre-market trading after declining 1.50 percent on Monday.
    Hallmark Financial Services, Inc. (NASDAQ: HALL) rose 6.5 percent to $10.68 in pre-market trading.
    Boot Barn Holdings, Inc. (NYSE: BOOT) rose 5.2 percent to $20.40 in pre-market trading after gaining 4.53 percent on Monday.
    New Oriental Education & Technology Group Inc. (NYSE: EDU) rose 5 percent to $91.16 in pre-market trading after reporting Q3 results.
    Shire plc (NASDAQ: SHPG) rose 5 percent to $167.98 in pre-market trading after Bloomberg reported that Takeda is nearing a preliminary agreement to acquire Shire after sweetened bid.
    Outfront Media Inc. (NYSE: OUT) shares rose 5 percent to $19.00 in pre-market trading.
    Geron Corporation (NASDAQ: GERN) rose 4.3 percent to $4.18 in pre-market trading after gaining 5.80 percent on Monday.
    SAP SE (NYSE: SAP) rose 3.7 percent to $109.80 in pre-market trading after the company posted strong quarterly results and raised its outlook for the year.
    Golden Ocean Group Limited (NASDAQ: GOGL) shares rose 3.7 percent to $8.70 in pre-market trading after gaining 1.45 percent on Monday.
    Deutsche Bank Aktiengesellschaft (NYSE: D
  • [By Stephan Byrd]

    Teekay Offshore Partners (NYSE: TOO) and Golden Ocean Group (NASDAQ:GOGL) are both small-cap transportation companies, but which is the superior investment? We will compare the two businesses based on the strength of their analyst recommendations, dividends, profitability, valuation, earnings, institutional ownership and risk.

  • [By Lisa Levin] Gainers
    Pacific Biosciences of California, Inc. (NASDAQ: PACB) rose 11.4 percent to $2.93 in pre-market trading.
    Check-Cap Ltd. (NASDAQ: CHEK) shares rose 6.3 percent to $4.76 in pre-market trading as the company announced the publication of CE Mark multicenter clinical study results on C-Scan® in Gut.
    Acacia Communications, Inc. (NASDAQ: ACIA) rose 6 percent to $ 35.20 in pre-market trading.
    Cellect Biotechnology Ltd. (NASDAQ: APOP) rose 6 percent to $7.60 in pre-market trading.
    Hexindai Inc. (NASDAQ: HX) rose 5.7 percent to $12.70 in pre-market trading.
    MoSys, Inc. (NASDAQ: MOSY) shares rose 5.3 percent to $2.07 in pre-market trading.
    Micron Technology, Inc. (NASDAQ: MU) rose 5 percent to $58.20 in pre-market trading after reporting a $10 billion buyback plan.
    Golden Ocean Group Limited (NASDAQ: GOGL) rose 4.1 percent to $8.63 in pre-market trading.
    MorphoSys AG (NASDAQ: MOR) rose 3.5 percent to $26.99 in pre-market trading.
    Cyren Ltd (NASDAQ: CYRN) shares rose 3.4 percent to $2.90 in pre-market trading. after reporting Q1 results.
    Box, Inc. (NYSE: BOX) rose 3.4 percent to $28.76 in pre-market trading.
    Kohl's Corporation (NYSE: KSS) shares rose 3.3 percent to $67.60 in the pre-market trading session after the company reported upbeat quarterly earnings.
    Micro Focus International plc (NYSE: MFGP) shares rose 3.1 percent to $18.40 in pre-market trading.

     

  • [By Motley Fool Staff]

    Golden Ocean Group (NASDAQ:GOGL) Q1 2018 Earnings Conference CallMay. 30, 2018 9:00 a.m. ET

    Contents:
    Prepared Remarks Questions and Answers Call Participants
    Prepared Remarks:

    Operator

Top 10 Value Stocks To Invest In Right Now

Asian private equity firm Affinity Equity Partners is nearing a deal to buy Trimco International Holdings Ltd., a Hong Kong-based maker of garment labels, people with knowledge of the matter said.

Affinity was chosen as the preferred bidder for Trimco and will now negotiate final terms of the purchase, according to the people, who asked not to be identified because the information is private. A deal could value Trimco, which is controlled by Partners Group Holding AG, at more than $500 million, one of the people said.

The offer from Affinity trumped bids by Baring Private Equity Asia and Nike Inc. supplier Yue Yuen Industrial Holdings Ltd., which were also among final suitors for Trimco, people with knowledge of the matter said earlier.

Trimco makes clothing care labels, woven labels, hang tags and radio frequency identification tags used for inventory management. Partners Group, the Swiss private equity firm, bought control of the business in 2012. Trimco has production facilities in countries including China, India, Romania, Singapore, Thailand and the U.K.

Top 10 Value Stocks To Invest In Right Now: Akebia Therapeutics, Inc.(AKBA)

Advisors’ Opinion:

  • [By Keith Speights]

    You might not have heard too much about Akebia Therapeutics (NASDAQ:AKBA), BioMarin Pharmaceutical (NASDAQ:BMRN), and Idera Pharmaceuticals (NASDAQ:IDRA). These are three biotech stocks that you could be overlooking — but deserve your attention. Here’s why.

  • [By Todd Campbell]

    After inking an expanded deal withOtsuka Pharmaceutical on its midstage anemia drug, shares ofAkebia Therapeutics (NASDAQ:AKBA)skyrocketed 33.4% today.

  • [By Alex McGuire]

    As a service to our readers, the following list provides the 10 top pharmaceutical stocks to watch this month (May 2017), including the biggest gainers from April…

    Pharmaceutical Stock Current Share Price April 2017 Gain
    Cleveland BioLabs Inc. (Nasdaq: CBLI) $3.62 +120.6%
    Nexvet Biopharma Plc. (Nasdaq: NVET) $6.61 +69.7%
    Motif Bio Plc. (Nasdaq ADR: MTFB) $10.10 +68.2%
    Axovant Sciences Ltd. (NYSE: AXON) $24.43 +62.3%
    Cyclacel Pharmaceuticals Inc. (Nasdaq: CYCC) $5.49 +46.7%
    Conatus Pharmaceuticals Inc. (Nasdaq: CNAT) $8.67 +44.9%
    Akebia Therapeutics Inc. (Nasdaq: AKBA) $13.07 +43.3%
    Akorn Inc. (Nasdaq: AKRX) $33.28 +38.9%
    Rockwell Medical Inc. (Nasdaq: RMTI) $8.78 +37.4%
    Akari Therapeutics Plc. (Nasdaq ADR: AKTX) $15.02 +35.4%

    The best-performing pharma stock of the month – Cleveland BioLabs Inc. – surged 120.6% to $3.53 a share by April 28. That crushed both the Nasdaq Biotech Index’s 1.5% gain and the Dow Jones’ 1.3% rise over the same period.

  • [By WWW.GURUFOCUS.COM]

    For the details of Novo A’s stock buys and sells, go to www.gurufocus.com/StockBuy.php?GuruName=Novo+A

    These are the top 5 holdings of Novo AInogen Inc (INGN) – 3,549,320 shares, 59.83% of the total portfolio. Acceleron Pharma Inc (XLRN) – 1,553,937 shares, 9.34% of the total portfolio. Dermira Inc (DERM) – 1,984,364 shares, 7.81% of the total portfolio. Shares added by 3.27%Corvus Pharmaceuticals Inc (CRVS) – 3,244,046 shares, 4.76% of the total portfolio. Akebia Therapeutics Inc (AKBA) – 2,225,000 shares, 4

Top 10 Value Stocks To Invest In Right Now: iShares Core S&P 500 (IVV)

Advisors’ Opinion:

  • [By WWW.KIPLINGER.COM]

    If youre not familiar, the VOO is one of three S&P 500-tracking ETFs the other two are the SPDR S&P 500 ETF Trust (SPY) and the iShares Core S&P 500 ETF (IVV). Each operates slightly differently, but at the end of the day, each provides very honest, tight tracking of the S&P 500. The VOO is simply the cheapest at just 0.05% in expenses, which accounts for most of the slight performance edge over its ETF brethren.

  • [By Todd Shriber, ETF Professor]

    Passive ETFs continuing to top active rivals is not all about the performance of U.S. stocks this year. Yes, the S&P 500 is up 5.5 percent year-to-date, but that is not a jaw-dropping performance. Much of the ongoing out-performance of passive ETFs over active counterparts this year is attributable to fees. Just look at the rock-bottom fees on ETFs such as the SPDR S&P 500 ETF (NYSE: SPY) and the iShares S&P 500 Core ETF (NYSE: IVV).

  • [By WWW.GURUFOCUS.COM]

    For the details of SWISS RE LTD’s stock buys and sells, go to www.gurufocus.com/StockBuy.php?GuruName=SWISS+RE+LTD

    These are the top 5 holdings of SWISS RE LTDiShares Core S&P 500 (IVV) – 1,274,000 shares, 41.43% of the total portfolio. Shares added by 114.84%SPDR S&P 500 (SPY) – 1,192,350 shares, 38.52% of the total portfolio. Shares added by 158.64%iShares MSCI EAFE (EFA) – 1,043,001 shares, 8.7% of the total portfolio. Shares added by 12.39%iShares Floating Rate Bond (FLOT) – 1,000,000 shares, 7.33% of the total portfolio. NewStar Financial Inc (NEWS) – 3,000,000 shares, 4.01%

Top 10 Value Stocks To Invest In Right Now: Golfsmith International Holdings Inc.(GOLF)

Advisors’ Opinion:

  • [By Jim Robertson]

    On Tuesday, our Under the Radar Moversnewsletter suggestedshorting small cap golf equipment stockAcushnet Holdings Corp (NYSE: GOLF):

    Acushnet Holdings has been on our watchlist for a while too, but it’s only been in the past few days we’ve seen the cracks start to appear.

  • [By Shane Hupp]

    DA Davidson reissued their hold rating on shares of Acushnet (NYSE:GOLF) in a research note published on Monday.

    A number of other research analysts have also issued reports on the stock. Morgan Stanley reiterated an overweight rating on shares of Acushnet in a report on Thursday, March 8th. ValuEngine upgraded shares of Acushnet from a hold rating to a buy rating in a report on Thursday, February 8th. SunTrust Banks reiterated a buy rating and issued a $26.00 price objective on shares of Acushnet in a report on Wednesday, April 11th. Compass Point lowered shares of Acushnet from a buy rating to a neutral rating and set a $24.00 price objective for the company. in a report on Monday, March 19th. Finally, KeyCorp reiterated an overweight rating on shares of Acushnet in a report on Thursday, March 8th. Five equities research analysts have rated the stock with a hold rating and five have issued a buy rating to the stock. The company presently has an average rating of Buy and a consensus target price of $23.40.

Top 10 Value Stocks To Invest In Right Now: SuperValu Inc.(SVU)

Advisors’ Opinion:

  • [By Stephan Byrd]

    SuperValu (NYSE:SVU) – Northcoast Research issued their Q1 2019 earnings per share estimates for SuperValu in a note issued to investors on Wednesday, May 9th. Northcoast Research analyst C. Cerankosky expects that the company will earn $0.65 per share for the quarter. Northcoast Research also issued estimates for SuperValu’s Q2 2019 earnings at $0.55 EPS, Q3 2019 earnings at $0.30 EPS, Q4 2019 earnings at $0.54 EPS and FY2019 earnings at $2.04 EPS.

  • [By Demitrios Kalogeropoulos]

    As for individual stocks, SUPERVALU (NYSE:SVU) and MSC Industrial (NYSE:MSM) stood out with big pricing moves after announcing quarterly business updates.

  • [By Peter Graham]

    Small cap grocery store stock SUPERVALU Inc (NYSE: SVU) reported Q1 2018 earnings this morning before the market opened with shares up more than 14% as Wholesale business results were outstanding. Net salesincreased 6.3% to$4.00 billion as Retail net sales were down 2.7% to $1.39 billion with the decrease reflecting identical store sales of negative 4.9% and closed stores, partially offset by sales from acquired and new stores.Total net sales within the Wholesale segment increased 12.4% to $2.56 billion primarily due to sales to new customers and increased sales to new stores operated by existing customers, partially offset by stores no longer being supplied by Supervalu and lower military sales. Retail identical store sales were negative 4.9% while fees earned under services agreements in the first quarter were $55 million versus $59 million last year. Net earnings from continuing operations was $12 million versus $20 million. The CEO commented:

  • [By Casey Wilson]

    Big grocery and supermarket chain stocks plummeted on June 16 when the deal was announced. Kroger Co. (NYSE: KR) sunk over 9.2%, Supervalu Inc. (NYSE: SVU) dropped 14.4%, and Wal-Mart Stores Inc. (NYSE: WMT) lost 4.7%. Meanwhile, AMZN enjoyed a nice 2.44% gain.

  • [By Jon C. Ogg]

    SUPERVALU Inc. (NYSE: SVU) was raised to Outperform from Sector Perform at RBC Capital Markets. Shares were indicated up 6% at $3.54 on Thursday.

    Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE) was indicated down 7% at $72.85 on Thursday due to results from a seizure medication study. It was downgraded to Neutral from Overweight at Piper Jaffray, and Wedbushlowered its target for the stock.

  • [By Demitrios Kalogeropoulos]

    As for individual stocks, RetailMeNot (NASDAQ:SALE) and SUPERVALU (NYSE:SVU) attracted heavy investor interest following merger and acquisition news.

Top 10 Value Stocks To Invest In Right Now: Polo Ralph Lauren Corporation(RL)

Advisors’ Opinion:

  • [By WWW.THESTREET.COM]

    The sidewalks outside stores like Armani, Dolce & Gabanna, Ralph Lauren (RL) , Gap (GPS) , Prada, Abercrombie & Fitch (AF) , Microsoft (MSFT) and Harry Winston are now lined with metal barricades. The strip commands some of the highest retail rents in the world, with the average annual rent being $3500 per square foot.

  • [By Ben Levisohn]

    Hanesbrands was just one of many retail companies that got shellacked this week. Under Armour (UAA) tumbled 29% after missing earnings forecasts and cutting its guidance, while Deckers Outdoor (DECK) plunged 21% after its earnings missed the Street consensus, and Ralph Lauren (RL) plummeted 13% after its CEO stepped down.

  • [By Casey Wilson]

    Ralph Lauren Corp. (NYSE: RL) just became the latest company to fall victim to the “Retail Ice Age.”

    The 50-year-old American icon announced it shuttered its flagship store at Fifth Avenue and 55th Street in New York City on Tuesday (April 4). It will also close 50 other retail locations by the end of the fiscal year.

  • [By Casey Wilson]

    Amazon has been a growing pain in the neck for low-price retailers like Wal-Mart Stores Inc. (NYSE:WMT) for some time, but even high-end specialty stores like Ralph Lauren Corp. (NYSE: RL) have struggled now that Amazon has crept into their sector.

  • [By Johanna Bennett]

    Times are tough for Ralph Lauren (RL). Profit and sales are fallingat theiconic clothingcompany, and investors who bet on a turnaround havelost their shirts on the stock. Adding to its troubles,CEO StefanLarsson is departingfollowing a creative clash with the companys namesake and founder.

    Pessimism, meanwhile, appears to be on the rise.

    According to a report by the financial analytics company S3 Partners, short interest in Ralph Lauren has risen since the start of the year, hitting historical levels. And while that short position is expected to keep expanding, bearish sentiments could turn on a dime.

    Ihor Dusaniwsky at S3 Partners writes:

    RL short interest levels, already at historical highs today, should continue to grow if the recent trend continues, but having made almost 23% in 2016 and 14% in 2017, short sellers may be quick to cover their positions and lock in profits if RLs stock price turns against them.

    Short interest in Ralph Lauren fell in 2016 as the stock price fella nd shorts covered positions, netting a return of 22.6%. So far this year, however, the short position as increased $226 million, or 38% to $815 million as of this morning, according to the S3 report.

    Its a profitable day for those short sellers. Todays 11% decline Ralph Laurens stock price on an $815 million short position has added $90 million to the short sellers collective bottom line.

    Ralph Lauren is down 11.5% in recent market actions to $77.26 a after earlier falling as low as $76.86 a share. Thats the lowest price for the stock since 2010.

Top 10 Value Stocks To Invest In Right Now: The First of Long Island Corporation(FLIC)

Advisors’ Opinion:

  • [By Dividends4Life]

    The First of Long Island Corporation (FLIC) operates as a bank holding company for The First National Bank of Long Island that provides financial services. Sept. 19, the company increased its quarterly dividend 4% to $0.26 per share. The dividend is payable Oct. 11, 2013 to shareholders of record on October 3, 2013. The yield based on the new payout is 2.7%.

Top 10 Value Stocks To Invest In Right Now: BAE Systems PLC (BAESY)

Advisors’ Opinion:

  • [By SEEKINGALPHA.COM]

    Rheinmetall is currently trading at 15.7x forward earnings and 2.5x book value, a valuation that is closer to its automotive suppliers peers. Compared to its defense peers, its valuation is clearly cheap, as shown in the next table. This shows that Rheinmetall is usually benchmarked against its auto peers, even though 53% of its sales and 41% of operating income have come from its defense unit in the past year.

    P/E P/BV Rheinmetall 15.7 2.5 Continental AG 12.4 2.9 Valeo 13.1 3.6 Brembo (OTC:BRBOF) 17.0 5.2 Leoni (OTC:LNNNY) 13.2 1.9 Auto Peers Average 14.3 3.2 Airbus 24.0 6.8 Leonardo 16.8 2.0 BAE Systems (OTCPK:BAESY) 18.5 5.7 Thales (OTCPK:THLEY) 22.4 4.3 Defense Sector Average 19.2 4.4

    Source: Bloomberg

  • [By WWW.THESTREET.COM]

    BAE Systems (BAESY) and other defense stocks gained on Friday morning after President Donald Trump’s strike on Syria prompted investors to consider the possibility of greater Western involvement in the Syrian conflict.

Top 10 Value Stocks To Invest In Right Now: Cliffs Natural Resources Inc.(CLF)

Advisors’ Opinion:

  • [By Lisa Levin]

    Basic materials shares rose by 0.74 percent in the US market on Friday. Top gainers in the sector included AK Steel Holding Corporation (NYSE: AKS), Cliffs Natural Resources Inc (NYSE: CLF), and United States Steel Corporation (NYSE: X).

  • [By Lisa Levin]

    In trading on Tuesday, basic materials shares fell 1.99 percent. Meanwhile, top losers in the sector included Cliffs Natural Resources Inc (NYSE: CLF), down 9 percent, and AK Steel Holding Corporation (NYSE: AKS), down 9 percent.

  • [By Lisa Levin] Gainers
    AGM Group Holdings Inc. (NASDAQ: AGMH) shares climbed 30.3 percent to $11.05 after climbing 34.60 percent on Thursday.
    Limelight Networks, Inc. (NASDAQ: LLNW) jumped 21.2 percent to $4.9699 following a first-quarter earnings beat. The company also raised its fiscal 2018 estimates.
    Telefonaktiebolaget LM Ericsson (NASDAQ: ERIC) shares climbed 18.8 percent to $7.89 after reporting strong Q1 earnings.
    Farmers Capital Bank Corp (NASDAQ: FFKT) gained 15.4 percent to $48.75. WesBanco Inc (NASDAQ: WSBC) announced an agreement and plan of merger with Farmers Capital Bank Corporation.
    TransUnion (NYSE: TRU) climbed 10.2 percent to $66.76 after the company posted upbeat Q1 results and issued a strong forecast for the second quarter. TransUnion announced plans to acquire Callcredit.
    Myomo, Inc. (NYSE: MYO) shares gained 9.2 percent to $3.9299 after rising 8.11 percent on Thursday.
    Pinnacle Foods Inc (NYSE: PF) gained 8.8 percent to $60.04 after a 13-D filing from Jana Partners showed an increased stake in the comapny, from 1.42 million shares at the end of last quarter to 10.83 million shares, or a 9.3-percent stake.
    Associated Banc-Corp (NYSE: ASB) shares climbed 8.8 percent to $26.70 following upbeat Q1 earnings.
    OFG Bancorp (NYSE: OFG) gained 8.5 percent to $12.80 after reporting Q1 results.
    Cleveland-Cliffs Inc. (NYSE: CLF) climbed 7.5 percent to $7.73 following Q1 results.
    Seaspan Corporation (NYSE: SSW) shares climbed 6.7 percent to $7.50. Deutsche Bank upgraded Seaspan from Hold to Buy.
    General Electric Company (NYSE: GE) shares rose 4.6 percent to $14.63 after the company reported better-than-expected earnings for its first quarter.
    Ionis Pharmaceuticals, Inc. (NASDAQ: IONS) rose 4.3 percent to $47.80. Biogen and Ionis have expanded their strategic collaboration to develop drug candidates for a broad range of neurological diseases.

    Check out these big penny stock gainers and losers

  • [By Lisa Levin]

    Thursday afternoon, the basic materials sector proved to be a source of strength for the market. Leading the sector was strength from United States Steel Corporation (NYSE: X) and Cliffs Natural Resources Inc (NYSE: CLF).

  • [By Tyler Crowe]

    No matter how much a commodity company like Cliffs Natural Resources (NYSE:CLF) tries, its fate will almost exclusively be in the hands of commodity prices. In the case of this past quarter, Cliffs was dealt a tougher hand as iron ore prices declined again. That may be enough to get some investors to head for the hills, but there were also some very promising signs that the company is setting itself up for a better long-term future.

Top 10 Value Stocks To Invest In Right Now: Deltic Timber Corporation(DEL)

Advisors’ Opinion:

  • [By Lisa Levin] Gainers
    Aimmune Therapeutics Inc (NASDAQ: AIMT) shares jumped 35 percent to $34.64 in response to failed DBVT peanut allergy trial.
    Exactech, Inc. (NASDAQ: EXAC) shares surged 30.9 percent to $41.88 after the company agreed to be acquired by TPG Capital for $42 per share in cash.
    Dextera Surgical Inc (NASDAQ: DXTR) shares climbed 27.6 percent to $0.238 after surging 40.48 percent on Friday.
    Petmed Express Inc (NASDAQ: PETS) jumped 21.8 percent to $44.73 as the company reported better-than-expected Q2 results.
    SenesTech Inc (NASDAQ: SNES) shares surged 21.7 percent to $1.95 after the company disclosed that Univar will be marketing and selling ContraPest.
    Yulong Eco-Materials Ltd (NASDAQ: YECO) shares gained 18.3 percent to $0.560.
    One Horizon Group Inc (NASDAQ: OHGI) shares rose 18 percent to $1.18.
    Atossa Genetics Inc (NASDAQ: ATOS) shares climbed 18 percent to $0.566. Atossa Genetics is schedule to host a conference call to announce preliminary results from Phase 1 study of oral Endoxifen on October 25, 2017.
    ReneSola Ltd. (ADR) (NYSE: SOL) shares rose 15.3 percent to $2.72
    Renren Inc (NYSE: RENN) shares gained 11.9 percent to $10.71 after gaining 2.68 percent on Friday.
    Kalvista Pharmaceuticals Inc (NASDAQ: KALV) shares rose 11.8 percent to $12.59. KalVista Pharma 13D filing from Longwood Fund showed registration for an 8.7 percent stake.
    Xunlei Ltd (NASDAQ: XNET) shares gained 9.4 percent to $7.20 after surging 25.33 percent on Friday.
    VF Corp (NYSE: VFC) shares surged 7.1 percent to $71.09 after the company reported upbeat earnings for its third quarter and raised its FY2017 guidance.
    CAI International Inc (NYSE: CAI) rose 6.6 percent to $39.70. Cowen & Co. upgraded CAI from Market Perform to Outperform.
    Agenus Inc (NASDAQ: AGEN) shares gained 5.7 percent to $4.58 as the company disclosed that GSK's shingle vaccine received FDA approval.
    Deltic Timber Corp (NYSE: DEL) shares climbed 5.6 percent to $94.11

Top 10 Value Stocks To Invest In Right Now: Extra Space Storage Inc(EXR)

Advisors’ Opinion:

  • [By Stephan Byrd]

    Extra Space Storage, Inc. (NYSE:EXR) hit a new 52-week high and low during trading on Tuesday . The company traded as low as $93.95 and last traded at $93.32, with a volume of 318074 shares changing hands. The stock had previously closed at $93.44.

  • [By Jon C. Ogg]

    Extra Space Storage Inc. (NYSE: EXR) was raised to Buy from Neutral at Merrill Lynch.

    ALSO READ: Jefferies Analysts Out With Top Stock Picks Before Global Tech Conference

    Goodyear Tire & Rubber Co. (NYSE: GT) was reiterated as Buy with a $36 price target (versus a $25.16 close) at Argus. The firm noted that the recent sell-off offers an attractive entry point.

  • [By Matthew Frankel]

    The final REIT type I like right now is self-storage, particularly Extra Space Storage (NYSE:EXR).

    First, I should mention that this could prove to be the most volatile company on the list. Self-storage isn’t as defensive as retail or healthcare simply because of its lease structure. Generally, you don’t sign a multi-year lease on a storage unit — you just pay each month that you want to keep it. This makes it easier for tenants to vacate the properties during tough times.

Best Insurance Stocks To Invest In Right Now

10 Sales Behaviors That Prospects Hate

12 Ways to Handle Awkward Business Networking Moments

Uninsured Rate Soars for the Moderately Broke : CDC

Indexed universal life insurance sales climbed to $485 million in the second quarter, up 10% from the total for the second quarter of 2016, according to Wink.

IUL sales were up from $447 million in the first quarter. 

(Related: Indexed Universal Life Sales Rise 3.4%: Wink) 

 Sheryl J. Moore, Wink’s president reported those figures in a summary of results from a survey of life insurance issuers.

Wink, which is based in Des Moines, Iowa, has been collecting IUL sales data for 20 years.

About 81% of the reported IUL sales were to purchasers who said their primary objective was cash accumulation, according to Wink. Other common IUL primary objectives include protecting and maximizing a death benefit and generating retirement income.  

Pacific Life Companies reported the highest IUL sales for the second quarter, and it was the market leader in terms of second-quarter IUL sales through banks and through independent agents. 

Best Insurance Stocks To Invest In Right Now: Daktronics, Inc.(DAKT)

Advisors’ Opinion:

  • [By Monica Gerson]

    Daktronics, Inc. (NASDAQ: DAKT) is estimated to report its quarterly earnings at $0.08 per share on revenue of $156.17 million. Daktronics shares slipped 0.13 percent to close at $7.97 on Tuesday.

  • [By Monica Gerson]

    Daktronics, Inc. (NASDAQ: DAKT) is projected to report its quarterly earnings at $0.08 per share on revenue of $156.17 million.

    Guidewire Software Inc (NYSE: GWRE) is estimated to post its quarterly earnings at $0.06 per share on revenue of $92.43 million.

Best Insurance Stocks To Invest In Right Now: Akebia Therapeutics, Inc.(AKBA)

Advisors’ Opinion:

  • [By Todd Campbell]

    After inking an expanded deal withOtsuka Pharmaceutical on its midstage anemia drug, shares ofAkebia Therapeutics (NASDAQ:AKBA)skyrocketed 33.4% today.

  • [By Lisa Levin]

    Shares of Akebia Therapeutics Inc (NASDAQ: AKBA) got a boost, shooting up 39 percent to $13.04. Akebia Therapeutics and Otsuka disclosed that they have expanded relationship with collaboration to develop and commercialize Vadadustat in Europe, China and other territories.

  • [By Alex McGuire]

    As a service to our readers, the following list provides the 10 top pharmaceutical stocks to watch this month (May 2017), including the biggest gainers from April…

    Pharmaceutical Stock Current Share Price April 2017 Gain
    Cleveland BioLabs Inc. (Nasdaq: CBLI) $3.62 +120.6%
    Nexvet Biopharma Plc. (Nasdaq: NVET) $6.61 +69.7%
    Motif Bio Plc. (Nasdaq ADR: MTFB) $10.10 +68.2%
    Axovant Sciences Ltd. (NYSE: AXON) $24.43 +62.3%
    Cyclacel Pharmaceuticals Inc. (Nasdaq: CYCC) $5.49 +46.7%
    Conatus Pharmaceuticals Inc. (Nasdaq: CNAT) $8.67 +44.9%
    Akebia Therapeutics Inc. (Nasdaq: AKBA) $13.07 +43.3%
    Akorn Inc. (Nasdaq: AKRX) $33.28 +38.9%
    Rockwell Medical Inc. (Nasdaq: RMTI) $8.78 +37.4%
    Akari Therapeutics Plc. (Nasdaq ADR: AKTX) $15.02 +35.4%

    The best-performing pharma stock of the month – Cleveland BioLabs Inc. – surged 120.6% to $3.53 a share by April 28. That crushed both the Nasdaq Biotech Index’s 1.5% gain and the Dow Jones’ 1.3% rise over the same period.

  • [By WWW.GURUFOCUS.COM]

    For the details of Novo A’s stock buys and sells, go to www.gurufocus.com/StockBuy.php?GuruName=Novo+A

    These are the top 5 holdings of Novo AInogen Inc (INGN) – 3,549,320 shares, 59.83% of the total portfolio. Acceleron Pharma Inc (XLRN) – 1,553,937 shares, 9.34% of the total portfolio. Dermira Inc (DERM) – 1,984,364 shares, 7.81% of the total portfolio. Shares added by 3.27%Corvus Pharmaceuticals Inc (CRVS) – 3,244,046 shares, 4.76% of the total portfolio. Akebia Therapeutics Inc (AKBA) – 2,225,000 shares, 4

  • [By Keith Speights]

    You might not have heard too much about Akebia Therapeutics (NASDAQ:AKBA), BioMarin Pharmaceutical (NASDAQ:BMRN), and Idera Pharmaceuticals (NASDAQ:IDRA). These are three biotech stocks that you could be overlooking — but deserve your attention. Here’s why.

Best Insurance Stocks To Invest In Right Now: RXI Pharmaceuticals Corporation(RXII)

Advisors’ Opinion:

  • [By Jim Robertson]

    Yesterday, our Under the Radar Moversnewsletter suggested small cap clinical-stage biotech RXi Pharmaceuticals Corp (NASDAQ: RXII) as a long/bullish trade for our short-term portfolio:

Top Stocks To Invest In 2018

April 7, 2017: Here are four stocks trading with relatively heavy volume among 60 equities making new 52-week lows in Friday’s session. On the NYSE, decliners led advancers by about 8 to 7 and on the Nasdaq advancers and decliners traded evenly, 1,400 to 1,409.

DryShips Inc. (NASDAQ: DRYS) dropped about 30% Friday to post a new 52-week low of $0.72 after closing at $1.03 on Thursday. Volume was about 15% above the daily average of around 31 million. The company said late Thursday that it will execute a 1-for-4 reverse stock split effective April 11. This marks the fifth reverse split in the firm’s stock in 13 months.

Valeant Pharmaceuticals International Inc. (NYSE: VRX) dropped about 2% Friday to post a new 52-week low of $9.44 after closing Thursday at $9.63. The stock’s 52-week high is $38.50. Volume of nearly 15 million shares was about 25% below the daily average of around 19.5 million. The stock is on track to post a gain of around 0.5% for the day following an offer from Fresenius SE to acquire Akorn. Barron’s suggests that investors must believe there’s a buyer for anything, so why not Valeant?

Top Stocks To Invest In 2018: Merck & Company, Inc.(MRK)

Advisors’ Opinion:

  • [By Paul Ausick]

    The DJIA stock posting the largest daily percentage gain ahead of the close Tuesday was Merck & Co. Inc. (NYSE: MRK) which traded up 6.19% at $62.29. The stock’s 52-week range is $53.63 to $66.80. Volume was more than three times the daily average of around 12.2million shares. The company’s lung cancer treatment drug met goals in a Phase 3 trial.

  • [By Arie Goren]

    Sales of Gileads blockbuster hepatitis C drugs Harvoni, Sovaldi and the new drug Epclusa, which was launched in the United States and Europe in June and July 2016, fell 16.6% compared to the previous quarter and 30.7% year-over-year to $3,325 million. The decline in Gileads HCV revenue has been mostly due to lower patient starts for Harvoni and lower revenues per patient, and the deep discount the company had to offer to maintain its high market share due to the competition from AbbVie’s (NYSE:ABBV)HCV drug Viekira, and Merck’s (NYSE:MRK)HCV drug Zepatier.

  • [By Ben Levisohn]

    Short story is, growth products are slowing and large net price increases are appearing increasingly unsustainable, even if the government doesn’t intervene. The innovation cycle appears to be in a waning period and, so far, large-caps with boatloads of cash seem to be hesitant to act. 2017 should have some excitement. We may finally see a successful registrational study in Alzheimer’s disease (Axovant Sciences’ (AXON) intepirdine or Merck’s (MRK) verubecestat), CAR T will finally get to plead its case, and we may find out once and for all if those ‘transformational’ PCSK9s are just that…

Top Stocks To Invest In 2018: DIRECTV(DTV)

Advisors’ Opinion:

  • [By Christopher Freeburn]

    Service disruptions on DirecTV’s (DTV) website temporarily interfered with subscribers’ ability to stream National Football League (NFL) games online for the last two Sundays.

Top Stocks To Invest In 2018: Akebia Therapeutics, Inc.(AKBA)

Advisors’ Opinion:

  • [By Alex McGuire]

    As a service to our readers, the following list provides the 10 top pharmaceutical stocks to watch this month (May 2017), including the biggest gainers from April…

    Pharmaceutical Stock Current Share Price April 2017 Gain
    Cleveland BioLabs Inc. (Nasdaq: CBLI) $3.62 +120.6%
    Nexvet Biopharma Plc. (Nasdaq: NVET) $6.61 +69.7%
    Motif Bio Plc. (Nasdaq ADR: MTFB) $10.10 +68.2%
    Axovant Sciences Ltd. (NYSE: AXON) $24.43 +62.3%
    Cyclacel Pharmaceuticals Inc. (Nasdaq: CYCC) $5.49 +46.7%
    Conatus Pharmaceuticals Inc. (Nasdaq: CNAT) $8.67 +44.9%
    Akebia Therapeutics Inc. (Nasdaq: AKBA) $13.07 +43.3%
    Akorn Inc. (Nasdaq: AKRX) $33.28 +38.9%
    Rockwell Medical Inc. (Nasdaq: RMTI) $8.78 +37.4%
    Akari Therapeutics Plc. (Nasdaq ADR: AKTX) $15.02 +35.4%

    The best-performing pharma stock of the month – Cleveland BioLabs Inc. – surged 120.6% to $3.53 a share by April 28. That crushed both the Nasdaq Biotech Index’s 1.5% gain and the Dow Jones’ 1.3% rise over the same period.

  • [By Todd Campbell]

    After inking an expanded deal withOtsuka Pharmaceutical on its midstage anemia drug, shares ofAkebia Therapeutics (NASDAQ:AKBA)skyrocketed 33.4% today.

  • [By Lisa Levin]

    Shares of Akebia Therapeutics Inc (NASDAQ: AKBA) got a boost, shooting up 39 percent to $13.04. Akebia Therapeutics and Otsuka disclosed that they have expanded relationship with collaboration to develop and commercialize Vadadustat in Europe, China and other territories.

  • [By Keith Speights]

    You might not have heard too much about Akebia Therapeutics (NASDAQ:AKBA), BioMarin Pharmaceutical (NASDAQ:BMRN), and Idera Pharmaceuticals (NASDAQ:IDRA). These are three biotech stocks that you could be overlooking — but deserve your attention. Here’s why.

  • [By WWW.GURUFOCUS.COM]

    For the details of Novo A’s stock buys and sells, go to www.gurufocus.com/StockBuy.php?GuruName=Novo+A

    These are the top 5 holdings of Novo AInogen Inc (INGN) – 3,549,320 shares, 59.83% of the total portfolio. Acceleron Pharma Inc (XLRN) – 1,553,937 shares, 9.34% of the total portfolio. Dermira Inc (DERM) – 1,984,364 shares, 7.81% of the total portfolio. Shares added by 3.27%Corvus Pharmaceuticals Inc (CRVS) – 3,244,046 shares, 4.76% of the total portfolio. Akebia Therapeutics Inc (AKBA) – 2,225,000 shares, 4